Damon Runyon Cancer Research Foundation   Report issue

Foundation Phase 1 Phase 2
Founded: New York City NY United States (1946)

Organization Overview

First Clinical Trial
2005
NCT00185731
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now